When it became known that there are two ovarian hormones, one having its origin in the granulosa cells of the Graafian follicle and the other emanating from the corpus luteum, the term " female sex hormone " led to some confusion. However, it still persisted to some extent, and was reserved for the hormone arising from the Graafian follicle. The essential feature of this hormone is that it has the power to produce oestrus in animals whose ovaries have been previously removed. The alternative names of oestrin and folliculin were therefore suggested, and the old term was gradually abandoned. After a few years' useful service the term " oestrin " gave rise to difficulty because several different chemical substances, all having the power of producing oestrus in animals, were isolated from the tissues of the human body. Moreover, compounds possessing similar properties were found in plants and minerals, and, more recently, others have been prepared synthetically. It is now customary, therefore, to speak of all chemical substances having the ability to promote oestrus as oestrogenic substances or oestrogens, and chemical nomenclature is used to distinguish them one from another.
Three such substances have been obtained from human tissues and body fluids, and are respectively called oestradiol, oestrone, and oestriol. There is reason to believe that they may be changed one into another under natural conditions and that they are produced as oestradiol but excreted for the most part as oestrone and oestriol. Oestradiol is secreted by the granulosa cells of the ovary in the non-pregnant woman, and by the placenta during pregnancy. For therapeutic purposes oestrone and oestradiol are most commonly employed, oestradiol being the more potent. Commercial preparations usually consist of benzoate or other esters of these compounds dissolved in oil. Such preparations are slowly absorbed after injection and thus exert a continuous and prolonged effect. Of the synthetic products only diethyl-stilboestrol (stilboestrol) is so far available for clinical use, and special mention of this substance will be made later. is of some importance, therefore, to be able to say when the body is deficient in these principles.
1. Conisiderationi of Symptoins.-Diminished secretion of oestradiol by the ovary leads to symptoms usually termed ",menopausal." Of these the commonest are amenorrhoea, an increase in weight, and hot flushes and other vasomotor disturbances. General symptoms, however, do not always appear when ovarian function is defective: this is particularly true in the case of young girls whose ovaries have never produced adequate amounts of oestradiol. Menopausal symptoms are experienced only by women whose ovaries have once been active. In youth the more common symptoms are amenorrhoea, oligomenorrhoea, under-development of breasts, and other sex characteristics such as pubic hair. When symptoms such as the above are present the following' more specific tests may be applied to clinch diagnosis.
2. Endowietrial Biopsy.-Proliferation of the endometrium is always the result of the action of oestrogenic principles, and in their absence atrophy occurs. An atrophic appearance is easily recognized microscopically, and is most typically seen in the post-menopausal endometrium. Removal of one or more pieces of endometrium for diagnostic purposes is a simple procedure, and unless the patient is virginal no anaesthetic is required. With suitable apparatus, dilatation of the cervix is unnecessary. In addition to endometrial biopsy, estimation of the size of the uterus by a sound is also a valuable procedure. A uterus smaller than normal, no matter whether it be under-developed or atrophic, is presumptive evidence of a lack of oestrogenic hormone in circulation. This evidence, however, is not always trustworthy, because even in the presence of an adequate supply of hormone the uterus may be incapable of response by reason of an inherent defect.
3. Exanatii1StionI of the Vaginia.-The epithelium of the healthy adult vagina contains large amounts of glycogen whose presence is essential for the production of lactic acid, the most important constituent of the vaginal " secretion." When the supply of oestrogenic hormone 'is inadequate the vaginal epithelium atrophies and tends to lose its layer of cornified cells, the amount of glycogen in its cells becomes diminished, and the degree of acidity of its " secretion" is lowered. Removal of epithelium is not necessary in practice examination of stained smears of vaginal debris is sufficient. The smear from a healthy vagina consists almost entirely of large keratinized squamous cells with small pyknotic nuclei (Plate, Fig. 2 is not yet clear, but there can be no doubt about its existence. Up to the age of puberty bone growth proceeds actively, and there is evidence to show that the subsequent ossification of the epiphyses and limitation of growth is the result of the establishment of full ovarian activity. Removal of the ovaries before puberty results in excessive bone growth, whilst pre-pubertal growth in animals is hindered by injection of oestrogenic substance. The ovarian hormone inhibits the production of growth hormone by the pituitary. With the lowered production of oestrogens at the menopause the pituitary is released from this inhibition, and the consequent liberation of larger amounts of growth hormone is possibly concerned in the aetiology of menopausal arthritis. Further evidence of the increased activity of growth hormone at the menopause is provided by the fact that many women at that time experience some enlargement of facial bones, resulting in a slightly acromegalic appearance. The use of oestrogenic hormone for menopausal arthritis, therefore, is not empirical, and is always worthy of trial.
Menopausal symptoms may persist for many years, and in some patients they do not appear until several years after the cessation of menses. This is because the cessation of menstruation (menopause) does not necessarily coincide with cessation of ovarian function (climacteric). When the onset of symptoms occurs late they are sometimes called climacteric symptoms, but they are similar in every way to those so frequently associated with the menopause.
They result from an oestrogenic hormone deficiency and respond equally well to treatment with this hormone. Disease of the Vulva and Vagina During two or three years after the menopause the tissues of the vulva and vagina undergo atrophy. Their local resistance is lowered and the vaginal secretion tends to become alkaline in reaction; secondary infection, therefore, is conmmon, and gives rise to the conditions of senile vaginitis and kraurosis vulvae. These are made manifest by discharge, pruritus, and dyspareunia. The discovery of oestrogenic principles has made it possible to restore the vulva and vagina to their adult healthy state in a very short time, and resistance is thereby so enhanced that the local infection is quickly overcome. The effects of the oestrogens are so great that a cure is possible without any local treatment. Nevertheless, the additional use of antiseptics is advantageous in that a cure is obtained more rapidly. For these conditions 5 mg. of oestradiol benzoa.e should be injected twice weekly, and the patient is usually free from symptoms in one to three weeks. It is unwise to stop treatment too early, however, and, even in cases apparently cured, small doses of hormone should be continued by mouth .for two to three months, otherwise the disease may relapse. Kraurosis vulvae, as a rule, requires more prolonged treatment, and the response is sometimes delayed for two to three months. In resistant cases complementary treatment with vitamin A is useful. When treatment has been suspended for four to six weeks the epithelium returns to its atrophic condition, but the symptoms do not recur unless reinfection takes place or unless treatment is discontinued before the lesions are completely healed.
In order to illustiate the value of oestrogenic hormone therapy in cases of senile vuivitis and vaginitis, the results of forty-three consecutive cases treated by Dr. A. A. Gemmell and me are presented. In thirty-five cases the vaginal lesion was predominant, whilst in eight the vulva was mainly affected. The details are shown in Tables I  and II. She complained of primary amenorrhoea, and investigation under general anaesthesia revealed a vagina so narrow that it would only admit a No. 9 rubber catheter, anid vaginal examination was impossible. The uterus felt so small on rectal palpation that there seemed no hope that the amenorrhoea could be cured. The breasts were also under-developed and the pubic hair absent. After this examination the narrow vagina was filled with a solution of sodium iodide. The radiograph (Fig. 3) shows that the upper vagina was well developed, whereas in its lower two inches it was very narrow. After two months' treatment with 80 mg. of oestradiol benzoate, the development of the lower vagina was such that the introitus appeared normal and bimanual examination was quite easy even without anaesthesia. Fluid opaque to x rays was again injected into the vagina, but this time the catheter had to be inserted through a large cork which was necessary to keep the fluid in the vagina. Fig. 4 SEPT. 30, 1939 OESTROGENIC I-IORMONE THERAPY development, but the breasts will atrophy at the conclusion of treatment unless ovarian function Is adequLate to maintain their integrity. This development of the breasts is often seen during the treatment of patients suIffering from amenorrhoea and may also occur in postmenopausal women receiving oestrogenic horm1one therapy for conditions sUch as senile vaginitis.
Chronic mastitis. or inVolutionary mastitks or imlastopathia, as it is variously termed, is most commonly seen in patients approaching the menopausal age. These nodular painful breasts benefit from continued treatment with the oestrogens. Once the breasts have been restored to normal by means of these hormones, however, great care needs to be exercised in gradually ieducing dosage. for sLudden cessation of treatment mas be lollowed baa retur-n of symptoms. Of recenit years the use of these principles for suppressing lactation has been widely advertised. Oestrogenic sUbstances, although stimulating breast development, do not bring about the secretion of milk-this is the function of an anterior pituitary hormone designated prolactin. Oestrogenic substances, by their inhibitory effect on the pituitary, actually suppress lactation, and their production by the placenta during pregnancy explains why lactation does not occur until the products of conception are expelled. Large amounts of oestradiol benzoate injected daily during the puerperiuLm undoubtedly inhibit lactation and breast engorgement, but once again the dose should be reduced gradually, otherwise the breasts may become engorged when treatment is suspended. It is cLaimed that sometimes even small doses of oestrone, 2 to 6 mg. taken by mouth during the coLurse of three to six days, are sufficient to prevent the discomfort of engorged breasts when, for any reason, breast feeding is contraindicated. More usually, daily injections of I to 2 mg. of oestradiol benzoate are required.
Other Indications for Treatment
In addition to the above applications of oestrogenic hormone therapy, however, it is used for infantilism, alopecia, facial hirsutes, migraine, haemophilia, peripheral vascular disease such as Raynaud's disease, and thromboangiitis obliterans, and also in certain pituitary disorders. A single dose of 5 mg. of oestradiol benzoate administered about the tenth or twelfth day of the menstrual cycle is believed, by means of its effect on the pituitary, to assist in ovulation and promote corpus luteum formation. It is therefore recommended for patients suffering from an ovular menstruation and sterility. Furthermore. oestrogens are advised for skin diseases such as acne, hyperpiesis of all types, hyperemesis gravidarum, diseases of the eye, and even urethral incontinence! Newborn babies do not escape from its administration, for it is claimed that premature babies thrive better if 0.05 mg. of oestrone is added to their diet each day.
It would seem that oestrogenic substances are in danger of being advertised as a " cure-all,"' and it is not sLirprising that the results of oestrogenic hormone therapy for these multituLdinous conditions and symptoms are very variable and, on the whole, disappointing. As a rule it is valueless tinless the condition in question is associated with puberty, the menopause, or some endocrine disturbance in which the diagnosis of a deficiency of oestrogenic hormone can be reasonably established.
The last indication for oestrogenic horm-one therapy that I wish to discuss is female sextial frigidity. It is logical to suippose that this condition would prove most amenable to oestrogens since, as their name iimplies, their essential characteristic is that they are responisible for oestrus in aninmals. Except under their Influence the feimiale animal will not receive the male. AlthoUgh post-menopausal women sometimes experience increased libido duLring oestrogenic hormone therapy for other conditions. patients complaining of sexual frigidity rarely, if cvei, derive any benefit fronm the administrationi of oestrogens. This finding is in accord with the knowxn clinical f,acts that there is no definite cycle of sex desire in woman and that se.x desire iS not uIsually dependent otn the state of ovarian activity. Loss cof Sexuial alppetite does niot often coincide with the menopaLse. and even nymphomania may occLur in women from whom all ovarianl tissuLI has been removed sUrgically. Human love anld kindred emotions are, for the most part, under the control of the central nervous system, and the cause of sexuLal disoi-dei-s is almost alway-s psychological rather than endocriniological, an1d sO is their treatment.
Untorard Effects of Ge3trogenic Hormone Therapy The oestr-ogens are e.sentially growth-promoting in their ellects. and it wsas at one time feared that their extended tise might result in the dexelopnment of neoplastic changi -particularly in the breast and Litertis. So far no clinical evidence has been brolught forward to stubstanitiate these fears, and most aLthorities regard the oestrogens, when used in ordinary dosage, as being harmless in this respect. However, it is of interest to note that in the series of forty-three patients treated for vaginitis and kraUlrosis vulvae, three developed carcinoma cervicis some months after oestrogen therapy. It is intended to publish separately the details of these cases, but it should be stated here that there is no definite evidence that the hormone administration was the cause of the neoplastic development. Nevertheless, these occurrences emphasize the importance of investigating the conditions of cervix and endometrium in middle-aged women before undertaking treatment with oestrogens. These substances are definitely contraindicated in the presence of any "pre-cancerous" lesion.
In children and post-menopausal patients painfuLl swelling of the breasts may occur during treatment; this, however, rapidly subsides when treatment is discontinued. Oestrogenic hormone therapy not infrequently provokes uterine haemorrhage in post-menopausal women. This appears to bear no definite relatio-n to the amount of hormone administered, and is of no seriouLs significance. Eight of the forty-three patients treated for senile conditions of the vagina and vulva experienced uterine bleeding diuring or after treatment.
So far as is known at present, the most harmful effect of oestrogenic substances is depression of ovarian activity.
Evidence shows that this is a real possibility, and it behoves us to be most careful in the treatment of young patients stuffering from oligomenorrhoea, dysmenorrhoea, and sterility. To minimize the risk to the ovaries in young patients, treatment should never be prolonged for more than a few months, and it shotuld be given intermittently rather than continuously. Stilboestrol The naturally occurring oestrogens are oil-soluble sterols all containing a phenanthrene ring. It was at one time considered that this chemical basis was essential for their oestrogenic properties. It was then discovered that compounds of a more simple structure may be oestrogenic, and recently one of these diethyl-stilboestrol (stilb-oestrol) has come to the fore. This compound can be prepared synthetically, and already its cost is much less than that of oestrone and oestradiol. Moreover, it can be administered orally or parenterally, and the evidence so far available shows that it is as active by mouth as it is by injection. One milligramme administered orally exerts an effect equal to that of the same amount of oestradiol benzoate injected intramuscularly. The only disadvantage is that stilboestrol in large doses frequently produces a sensation of nausea and malaise. This occurs after parenteral as well as oral administration. It is doubtful whether stilboestrol, which, so far as we know, does not occur naturally, should be regarded as a "hormone." I prefer to regard it as a hormone substitute.
Stilboestrol, even when given by mouth, has been shown to produce good results in the treatment of genital hypoplasia, amenorrhoea, menopausal symptoms, senile vaginitis and vulvitis, suppression of lactation, and, in fact, all the conditions for which oestradiol and oestrone have proved their value. Moreover, I have used it with success to induce labour in cases of intra-uterine death of the foetus. The dosage laid down for oestradiol should form the basis of stilboestrol therapy, but when it is administered by mouth it is advisable to give it more frequently and in slightly larger quantities. The same principles of treatment should be followed, and it is rarely necessary to give more than 5 mg. daily.
At the present time stilboestrol therapy is still in the trial stage, but the initial reports go to prove its value. Figs. 1 and 2 illustrate the effect of stilboestrol on the vaginal epithelitum. The original smear (Fig. 1) The efficacy of stilboestrol is further evidenced by a recent case of kraurosis vulvae occurring in a woman aged 72. The condition had been presenit for five years, during which time she had received all manner of treatment, including x-ray therapy on two occasions. No form of treatment had given her more than slight and temporary relief from her intense pruritus. When the patient was first seen by the author the vulva showed a severe degree of kraurosis vulvae with superimposed ulceration and induration-the result of scratching. The lightest touch produced unbearable pain (Fig. 5) . Large doses of stilboestrol were given by intramuscular injection and also by mouth. In the course of seventeen days she received 220 mg. of stilboestrol (probably an tinnecessarily large dose), but no other treatment except the local application of an analgesic ointment to ensure sleep. At the end of that time the second photograph (Fig. 6) was taken, and this shows the vulva completely healed except for two small ulcers. The patient was then given 3 mg. of stilboestrol daily, and one month later she was free from symptoms and the kraurosis was cured.
Hormone therapy is, no doubt, still in a crude state, but already it has passed beyond the stage of " gland extracts." Oestrogenic substances, both natural and synthetic, are pure chemical compounds dispensed by weight and possessing remarkable properties. It is truly amazing that such small amounts of material can exert such pronounced local and general effects. Stilboestrol is an adequate substitute for the natural oestrogens, and possesses advantages in that it is cheaper and is also equally active when administered by mouth. Treatment must, however, be based on physiological principles, and often needs to be prolonged for some time before its full effect is manifest. Careful selection of cases suitable for treatment is essential, and the empirical use of oestrogenic substances can only lead to disappointment. Less than three-years ago we published a brief paper on an entity then regarded as extremely rare, the tumour of the neuro-myo-arterial glomus (Mackey and Lendrum, 1936) . In concluding our paper we quoted the aphorism of Picard (1931) , that recognition of this, as of all rarities, demands only that it be borne in mind: the truth of this has been strikingly shown by the fact that in the intervening brief period we have seen a further twelve cases. Since the lesion is one which is usually productive of quite crippling pain in its victim, and since its treatment, too often unreasonably delayed, is of the simplest and most satisfactory nature, it appears desirable to bring this interesting little tumour to more general notice. It would be surprising had a lesion,with such a clamant syndrome remained quite unobserved, and indeed there can be little doubt that tumours of this nature must have constituted a portion of the group described in 1812 by Wood as painful subcutaneous tubercle (Greig, 1928) ; but its histological identification had to await the work of Masson (1924) , who also suggested its probable origin from the normal arteriovenous anastomoses present in the skin.
Clinical Features It is characteristic of these cases that symptoms greatly overshadow signs. The patient presents himself because of pain, usually in a limb, and generally paroxysmal. In many cases the pain is related to a " trigger point," sensitive to a minimum of trauma; in others the attacks are elicited by change of temperature or even by change of position ; whilst attacks no less severe may seem entirely spontaneous in origin. If the tumour lie in the fatty subcutaneous tissue it may take the form of a bluish nodule of angiomatous appearance, which has frequently been observed to engorge during a painful attack. The patient, however, may fail to observe the nodule or to relate it to his pain. In some cases, especially if the lesion be subungual, no abnormality is to be seen.
Inquiry usually elicits the fact that the symptoms have developed gradually, sometimes over many years, and frequently the onset is related to a single obvious trauma, especially in the subungual tumours. The typical pain is often preceded by vague tinglings and mild discomforts; it is at first moderate in degree, local in distribution, and merely occasional, but it tends to increase in severity, to radiate more and more widely, and to occur with greater frequency. Ultimately the pain is agonizing, and the patient may even demand amputation of an affected finger * Read in the Section of Pathology and Bacterio)logy at ihe 
